Lisa Rogers, DO
Neurology · Wyandotte, MINPI 1124109251
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,000 of the $5,030 with a category attached, or 79.5%. Novocure Inc. accounts for 99.4% of it on its own, with 2 other manufacturers making up the rest.
Across 13 payments — averaging $386.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$5K
- Medline Industries LP$17
- Acadia Pharmaceuticals Inc$14
Across 20 payments — averaging $8822.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$176K
What the payments were for
- Speaking & faculty fees$4,00080%
- Travel & lodging$57611%
- Food & beverage$4549%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 11 | $4,999 |
| Medline Industries LP | 1 | $17 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oncology$4,710
How this compares
$5,030 in reported general payments places this provider in the 70th percentile of 652 neurology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 23 | $1,202 |
| Lacosamide | 30 | $1,201 |
| Duloxetine Hcl | 56 | $1,196 |
| Dexamethasone | 20 | $585 |
| Levetiracetam | 17 | $561 |
| Gabapentin | 41 | $451 |
| Pregabalin | 25 | $388 |
Paid to pharmacies, not to this prescriber.
Other neurology in Wyandotte
- Aaron EllenbogenFarmington Hills$1.6M
- Matthew HoltzmanWayne$1.4M
- Richard TroschFarmington Hills$1.2M
- Wade CooperAnn Arbor$991K
- Bisena BulicaDetroit$900K
- Julie BurnhamMount Clemens$836K
- Amit MasihOkemos$785K
- Martin BelkinFarmington Hills$712K
- Robert PaceOwosso$693K
- Rosemarie WalchOwosso$563K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.